While they're not the typical sufferers one thinks of when one hears about the rampant abuse of opioids in the country today, Medicare beneficiaries should be included in the picture — and they could be getting the short end of the stick when it comes to help.
Kaiser Health News reported that a research letter published by JAMA Psychiatry said that the beneficiaries of Medicare have the highest, and the fastest-growing, rate of "opioid use disorder." One out of every thousand patients covered by commercial insurance plans is a sufferer, but among Medicare patients, that number swells to 6 out of every 1,000.
The letter said that Medicare beneficiaries could be falling through the cracks when it comes to treatment, too. While 2013 saw a high level of opioid prescription painkillers for Medicare patients, doctors were far less often prescribing buprenorphine-naloxone, which is the only effective drug therapy for opioid use disorder covered by Medicare Part D.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
